These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17170456)

  • 1. OTK18, a zinc-finger protein, regulates human immunodeficiency virus type 1 long terminal repeat through two distinct regulatory regions.
    Horiba M; Martinez LB; Buescher JL; Sato S; Limoges J; Jiang Y; Jones C; Ikezu T
    J Gen Virol; 2007 Jan; 88(Pt 1):236-241. PubMed ID: 17170456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of a putative antiretroviral transcriptional factor, OTK18.
    Carlson KA; Leisman G; Limoges J; Pohlman GD; Horiba M; Buescher J; Gendelman HE; Ikezu T
    J Immunol; 2004 Jan; 172(1):381-91. PubMed ID: 14688346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YY1 and FoxD3 regulate antiretroviral zinc finger protein OTK18 promoter activation induced by HIV-1 infection.
    Buescher JL; Martinez LB; Sato S; Okuyama S; Ikezu T
    J Neuroimmune Pharmacol; 2009 Mar; 4(1):103-15. PubMed ID: 19034670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1.
    Giacca M; Gutierrez MI; Menzo S; d'Adda di Fagagna F; Falaschi A
    Virology; 1992 Jan; 186(1):133-47. PubMed ID: 1727595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
    Murphy KM; Sweet MJ; Ross IL; Hume DA
    J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human immunodeficiency virus type 1 replication by a cellular transcriptional factor MBP-1.
    Ray RB; Srinivas RV
    J Cell Biochem; 1997 Mar; 64(4):565-72. PubMed ID: 9093905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter.
    Kundu M; Srinivasan A; Pomerantz RJ; Khalili K
    J Virol; 1995 Nov; 69(11):6940-6. PubMed ID: 7474112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.
    Verhoef K; Sanders RW; Fontaine V; Kitajima S; Berkhout B
    J Virol; 1999 Feb; 73(2):1331-40. PubMed ID: 9882338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat.
    Zeichner SL; Kim JY; Alwine JC
    J Virol; 1991 May; 65(5):2436-44. PubMed ID: 2016766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein.
    Zhang JL; Sharma PL; Crumpacker CS
    Virology; 2000 Mar; 268(2):251-63. PubMed ID: 10704334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic transcription factor GATA-2 activates transcription from HIV-1 long terminal repeat.
    Towatari M; Kanei Y; Saito H; Hamaguchi M
    AIDS; 1998 Feb; 12(3):253-9. PubMed ID: 9517987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages.
    Moses AV; Ibanez C; Gaynor R; Ghazal P; Nelson JA
    J Virol; 1994 Jan; 68(1):298-307. PubMed ID: 8254741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity.
    Kliewer S; Garcia J; Pearson L; Soultanakis E; Dasgupta A; Gaynor R
    J Virol; 1989 Nov; 63(11):4616-25. PubMed ID: 2529378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1.
    Coull JJ; Romerio F; Sun JM; Volker JL; Galvin KM; Davie JR; Shi Y; Hansen U; Margolis DM
    J Virol; 2000 Aug; 74(15):6790-9. PubMed ID: 10888618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and purification of a novel transcriptional repressor from HeLa cell nuclear extracts recognizing the negative regulatory element region of human immunodeficiency virus-1 long terminal repeat.
    West M; Mikovits J; Princler G; Liu YL; Ruscetti FW; Kung HF; Raziuddin
    J Biol Chem; 1992 Dec; 267(35):24948-52. PubMed ID: 1459999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors.
    Zhao C; Chen Y; Park J; Kim JB; Tang H
    Biochem Biophys Res Commun; 2004 Sep; 322(2):614-22. PubMed ID: 15325274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of protein-DNA interaction in adeno-associated virus Rep78-mediated inhibition of HIV-1.
    Kokorina NA; Santin AD; Li C; Hermonat PL
    J Hum Virol; 1998; 1(7):441-50. PubMed ID: 10195265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for regulation of long terminal repeat transcription by Wnt transcription factor TCF-4 in human astrocytic cells.
    Wortman B; Darbinian N; Sawaya BE; Khalili K; Amini S
    J Virol; 2002 Nov; 76(21):11159-65. PubMed ID: 12368361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.